Published in Pediatr Int on April 01, 1999
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Antimicrobial resistance of Escherichia coli O157 isolated from humans, cattle, swine, and food. Appl Environ Microbiol (2002) 1.87
Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol (2001) 1.82
Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. J Clin Microbiol (2002) 1.10
Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals. Toxins (Basel) (2012) 1.10
Genetic differentiation of Escherichia coli O157:H7 clades associated with human disease by real-time PCR. J Clin Microbiol (2008) 1.08
Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7. Microbiology (2009) 1.01
Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence. Appl Environ Microbiol (2013) 1.01
Interventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic review. BMC Public Health (2013) 0.96
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide. Pediatr Nephrol (2011) 0.96
Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun (2008) 0.94
Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae. Foodborne Pathog Dis (2013) 0.93
Life on the outside: role of biofilms in environmental persistence of Shiga-toxin producing Escherichia coli. Front Microbiol (2014) 0.91
Alfalfa seed decontamination in a Salmonella outbreak. Emerg Infect Dis (2003) 0.89
Management of diarrhea-associated hemolytic uremic syndrome in children. Clin Exp Nephrol (2008) 0.85
Identification and characterization of spontaneous deletions within the Sp11-Sp12 prophage region of Escherichia coli O157:H7 Sakai. Appl Environ Microbiol (2013) 0.82
Overview and Historical Perspectives. Microbiol Spectr (2014) 0.81
Complement, thrombotic microangiopathy and disseminated intravascular coagulation. J Intensive Care (2014) 0.80
Thrombotic microangiopathy: E. coli O104:H4 German outbreak: a missed opportunity. Nat Rev Nephrol (2012) 0.79
Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran. Iran J Microbiol (2013) 0.76
Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes. PLoS One (2015) 0.76
Workers' load and job-related stress after a reform and work system change in a hospital kitchen in Japan. Environ Health Prev Med (2012) 0.75
Successful colonoscopic approach in a child with intussusception associated with enterohemorrhagic Escherichia coli O157 infection. Pediatr Rep (2012) 0.75
Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides. Antimicrob Agents Chemother (2015) 0.75
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrob Agents Chemother (1980) 5.47
Age-associated characteristics of murine hematopoietic stem cells. J Exp Med (2000) 4.65
Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell (1993) 4.04
Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 3.76
The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science (1993) 2.77
Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. J Virol (1987) 2.51
Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A (1998) 2.31
Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet (1986) 2.29
Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med (1994) 2.27
The histidine permease gene (HIP1) of Saccharomyces cerevisiae. Gene (1985) 2.20
RNA and protein catalysis in group II intron splicing and mobility reactions using purified components. Biochemistry (1999) 2.20
A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II. Biochem Biophys Res Commun (1995) 2.19
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study. Aliment Pharmacol Ther (2013) 2.13
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12
Structural characterization of U*-1915 in domain IV from Escherichia coli 23S ribosomal RNA as 3-methylpseudouridine. Nucleic Acids Res (1996) 2.07
Dietary selenium affects methylation of the wobble nucleoside in the anticodon of selenocysteine tRNA([Ser]Sec). J Biol Chem (1993) 2.05
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sci U S A (1998) 1.90
In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity. Antimicrob Agents Chemother (1993) 1.85
Mass spectrometry of mRNA cap 4 from trypanosomatids reveals two novel nucleosides. J Biol Chem (1992) 1.85
A reverse transcriptase/maturase promotes splicing by binding at its own coding segment in a group II intron RNA. Mol Cell (1999) 1.83
Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials (2001) 1.81
Detection of a noble gas molecular ion, 36ArH+, in the Crab Nebula. Science (2013) 1.80
Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res (1984) 1.80
Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives. Chem Pharm Bull (Tokyo) (1993) 1.80
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther (2008) 1.77
Incidence of arthro-osteitis in patients with pustulosis palmaris et plantaris. Ann Rheum Dis (1981) 1.77
An optical spectrum of the afterglow of a gamma-ray burst at a redshift of z = 6.295. Nature (2006) 1.70
[Electron microscopic studies on peroxidase and acid phosphatase reaction in human leukocytes (in normal and leukemic cells and on phagocytosis)]. Nihon Ketsueki Gakkai Zasshi (1966) 1.70
Structure of rice ferricytochrome c at 2.0 A resolution. J Mol Biol (1983) 1.67
Training 'greeble' experts: a framework for studying expert object recognition processes. Vision Res (1998) 1.65
Deoxyribonucleic acid analyses of five families with familial inherited thyroid stimulating hormone deficiency. J Clin Endocrinol Metab (1990) 1.64
Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis (1981) 1.62
The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum (1997) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.60
Posttranscriptional modification of tRNA in thermophilic archaea (Archaebacteria). J Bacteriol (1991) 1.57
Eosinophilic gastroenteritis involving the entire digestive tract. Am J Gastroenterol (1995) 1.55
Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri. Antimicrob Agents Chemother (1980) 1.52
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol (2000) 1.50
Clinical features of 22 cases with "inter-sterno-costo-clavicular ossification". A new rheumatic syndrome. Arch Orthop Trauma Surg (1979) 1.49
Enumeration, isolation, and species identification of mycoplasmas in saliva sampled from the normal and pathological human oral cavity and antibody response to an oral mycoplasma (Mycoplasma salivarium). J Clin Microbiol (1986) 1.48
SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity (2001) 1.47
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem (1985) 1.47
Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions. J Biochem (1986) 1.47
Helicobacter pylori of the remnant stomach and its eradication. Hepatogastroenterology (1999) 1.47
Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. Cancer Res (2000) 1.46
Warm water vapour in the sooty outflow from a luminous carbon star. Nature (2010) 1.45
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother (1980) 1.45
Three distinct forms of type 2A protein phosphatase in human erythrocyte cytosol. J Biol Chem (1988) 1.45
Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J Gastroenterol (1999) 1.43
Polyclonal B-cell lymphocytosis with features resembling hairy cell leukemia-Japanese variant. Blood (1997) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
A Lipoxygenase Pathway Is Activated in Rice after Infection with the Rice Blast Fungus Magnaporthe grisea. Plant Physiol (1991) 1.41
Conformational flexibility in RNA: the role of dihydrouridine. Nucleic Acids Res (1996) 1.41
Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene (1992) 1.40
Antiferromagnetic order as the competing ground state in electron-doped Nd1.85Ce0.15CuO4. Nature (2003) 1.40
Transcription of the Trypanosoma brucei spliced leader RNA gene is dependent only on the presence of upstream regulatory elements. Mol Biochem Parasitol (1997) 1.40
The performance of a novel ball-tipped Flush knife for endoscopic submucosal dissection: a case-control study. Aliment Pharmacol Ther (2010) 1.39
Prevalence of Bartonella species and 16s rRNA gene types of Bartonella henselae from domestic cats in Thailand. Am J Trop Med Hyg (2001) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
The acceleration of cosmic-ray protons in the supernova remnant RX J1713.7-3946. Nature (2002) 1.38
Implication of myocardial lactate metabolism during coronary artery bypass grafting. Cardiovasc Surg (1997) 1.38
Detoxification of cadmium in tobacco plants: formation and active excretion of crystals containing cadmium and calcium through trichomes. Planta (2001) 1.37
Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett (1991) 1.37
Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities. Eur J Biochem (1984) 1.37
A two-component multidrug efflux pump, EbrAB, in Bacillus subtilis. J Bacteriol (2000) 1.37
Enhanced replication of human cytomegalovirus in human fibroblasts treated with dexamethasone. J Gen Virol (1984) 1.37
Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant (1994) 1.35
Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol (2009) 1.35
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
IgE-mediated histamine release in rat basophilic leukemia cells: receptor activation, phospholipid methylation, Ca2+ flux, and release of arachidonic acid. Arch Biochem Biophys (1981) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol (1988) 1.32
cDNA cloning of rice lipoxygenase L-2 and characterization using an active enzyme expressed from the cDNA in Escherichia coli. Eur J Biochem (1992) 1.31
Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J Biol Chem (2001) 1.31
Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials (1999) 1.31
Toxicological research on substances from Fusarium nivale. 3. The structure of nivalenol and its monoacetate. Tetrahedron Lett (1969) 1.29
Retrospective study of technical aspects and complications of endoscopic submucosal dissection for laterally spreading tumors of the colorectum. Endoscopy (2010) 1.29
Nucleotide sequence and expression of the Enterobacter aerogenes alpha-acetolactate decarboxylase gene in brewer's yeast. Appl Environ Microbiol (1988) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Allergenic activity of heated and ovomucoid-depleted egg white. J Allergy Clin Immunol (1997) 1.27
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology (Oxford) (2006) 1.27
Inhibition of the protein synthesis in rabbit reticulocyte by Nivalenol, a toxic principle isolated from Fusarium nivale-growing rice. J Biochem (1968) 1.27
Metabolic abnormalities associated with postoperative organ failure. A redox theory. Arch Surg (1983) 1.27
Nonsurgical treatment of unruptured intracranial vertebral artery dissection with serial follow-up angiography. J Neurosurg (1994) 1.26
Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol (1980) 1.25
A novel modified nucleoside found at the first position of the anticodon of methionine tRNA from bovine liver mitochondria. Biochemistry (1994) 1.25
Preparation and microstructure analysis of chitosan/hydroxyapatite nanocomposites. J Biomed Mater Res (2001) 1.25
[Primary structure and function of beta-amylase]. Seikagaku (1988) 1.24
MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res (2001) 1.24